Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA

Rio de Janeiro, Rio de Janeiro 20230-130

0 studies enrolling now · 3 studies all time

What they study most

Acute Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Chronic Myelogenous Leukemia (CML), Hematological Malignancies, Lymphoma, Melanoma, Myelodysplastic Syndrome (MDS), Neoplasms

Studies at this site

• A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer — Running, not enrolling
• A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma — Running, not enrolling
• Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS — Completed